Oral Rifaximin Soluble Solid Dispersion Immediate-Release 40 mg Prevents Development of Cirrhosis-Related Complications: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共1页
• 作者

  Bajaj Jasmohan S.; Flamm Steven L.; Chalasani Naga; Diaz Ernesto; Kayali Zeid; Kang Robert; Bortey Enoch; Wolf Ray A.; Sanya Arun J. I;

  展开▼
• 作者单位

  McGuire VA Med Ctr Richmond VA USA;

  Northwestern Univ Feinberg Sch Med Chicago IL 60611 USA;

  Indiana Univ Sch Med Indianapolis IN 46202 USA;

  Linfritz Res Inst Inc Coral Gables FL USA;

  Inland Empire Liver Fdn Rialto CA USA;

  Salix Pharmaceut Raleigh NC USA;

  Salix Pharmaceut Raleigh NC USA;

  Salix Pharmaceut Raleigh NC USA;

  McGuire VA Med Ctr Richmond VA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词